Table 1 Demographic, clinical, and laboratory data of the participants; RHf (−) and RHf (+) groups.
From: Urinalysis of individuals with renal hyperfiltration using ATR-FTIR spectroscopy
Parameters | RHf (−) Group (n = 20) | RHf ( +) Group (n = 17) | p | |||
|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | |||
Gender | Female, %(n) | 50% (10) | 52.9% (9) | 0.892* | ||
Male, %(n) | 50% (10) | 47.1% (8) | ||||
Smoking | Yes, %(n) | 30% (6) | 17.6% (3) | 0.299* | ||
No, %(n) | 70% (14) | 82.4% (14) | ||||
Age, year | 39.2 | 11.8 | 38.7 | 12.2 | 0.892 | |
BMI, kg m2 | 24.3 | 2.9 | 24.9 | 3.0 | 0.594 | |
SBP, mm Hg | 109.5 | 6.1 | 118.5 | 10.8 | 0.006 | |
DBP, mm Hg | 70.8 | 6.1 | 75.8 | 10.6 | 0.097 | |
MAP, mm Hg | 83.6 | 7.4 | 94.5 | 11.4 | 0.002 | |
PP, mm Hg | 40.1 | 3.5 | 44.0 | 5.6 | 0.014 | |
P, beats/min | 73.4 | 8.4 | 78.6 | 11.4 | 0.131 | |
FBG, mg/dl | 90.2 | 7.4 | 87.8 | 6.6 | 0.317 | |
Urea, mg/dl | 24.1 | 6.5 | 26.3 | 6.0 | 0.294 | |
Creatinine, mg/dl | 0.78 | 0.17 | 0.68 | 0.20 | 0.135 | |
Uric acid, mg/dl | 4.5 | 1.13 | 4.5 | 1.1 | 0.881 | |
Triglyceride, mg/dl | 93.6 | 42.6 | 111.5 | 18.6 | 0.378 | |
T. Cholesterol, mg/dl | 182.9 | 29.3 | 201.3 | 36.4 | 0.097 | |
LDL, mg/dl | 119.5 | 20.5 | 130.8 | 25.2 | 0.143 | |
HDL, mg/dl | 51.6 | 12.4 | 52.8 | 13.8 | 0.798 | |
Albumin, g/dl | 4.4 | 0.4 | 4.4 | 0.3 | 0.529 | |
Na, mmol/l | 139.2 | 1.6 | 139.4 | 1.9 | 0.784 | |
K, mmol/l | 4.4 | 0.4 | 4.3 | 0.3 | 0.213 | |
Cl, mmol/l | 104.0 | 1.9 | 104.2 | 1.9 | 0.713 | |
Ca, mg/dl | 9.9 | 0.3 | 9.8 | 0.4 | 0.480 | |
P, mg/dl | 3.4 | 0.5 | 3.3 | 0.6 | 0.659 | |
Mg, mg/dl | 2.1 | 0.1 | 2.1 | 0.1 | 0.546 | |
eGFR (CKD-EPI), ml/min/1.73 m2 | 106.1 | 20.1 | 115.11 | 18.5 | 0.136 | |
Clcr, ml/min/1.73 m2 | 106.4 | 11.4 | 157.7 | 21.0 | < 0.001 | |
Proteinuriaδ, mg/day | 114.2 | 51.6 | 182.3 | 54.3 | < 0.001 | |
Albuminuriaδ, mg/day Median, IQR | 4.0 | 2.1–7.0 | 8.9 | 5.5–12.7 | 0.021** | |
Naδ, mmol/l | 67.1 | 22.3 | 72.9 | 41.5 | 0.590 | |
